ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY
Aim. To study antihypertensive efficacy and safety of valsartan (Diovan, Novartis Pharma) as well as patient’s compliance to the mono- or combined valsartan based therapy in smoking vs non-smoking hypertensive patients.Material and methods. It was a prospective multicenter observation study. 114 doc...
| 發表在: | Рациональная фармакотерапия в кардиологии |
|---|---|
| Main Authors: | , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Столичная издательская компания
2016-01-01
|
| 主題: | |
| 在線閱讀: | https://www.rpcardio.online/jour/article/view/766 |
